ROYAL BANK OF CANADA - EIDOS THERAPEUTICS INC ownership

EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 1 filers reported holding EIDOS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of EIDOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$6,000
+200.0%
48
-2.0%
0.00%
Q1 2020$2,000
-71.4%
49
-64.0%
0.00%
Q4 2019$7,000
+250.0%
136
+166.7%
0.00%
Q3 2019$2,0000.0%510.0%0.00%
Q2 2019$2,000
+100.0%
510.0%0.00%
Q1 2019$1,000
-75.0%
51
-79.3%
0.00%
Q4 2018$4,000
+33.3%
246
-25.2%
0.00%
Q3 2018$3,0003290.00%
Other shareholders
EIDOS THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,123,630$53,563,00020.44%
Board of Trustees of The Leland Stanford Junior University 265,670$12,664,00010.90%
Opaleye Management Inc. 315,550$14,634,0002.96%
RA Capital Management 2,162,671$103,095,0002.01%
Cormorant Asset Management, LP 1,055,302$50,306,0001.92%
Parkman Healthcare Partners LLC 41,085$1,959,0000.55%
Redmile Group, LLC 593,842$28,308,0000.52%
Perceptive Advisors 686,922$30,115,0000.49%
HighVista Strategies LLC 10,596$505,0000.42%
Ikarian Capital, LLC 100,000$4,767,0000.38%
View complete list of EIDOS THERAPEUTICS INC shareholders